Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Takeda Pharmaceutical Co. Ltd (TAK)

Takeda Pharmaceutical Co. Ltd (TAK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,384,940
  • Shares Outstanding, K 3,152,750
  • Annual Sales, $ 30,279 M
  • Annual Income, $ 407,020 K
  • 60-Month Beta 1.09
  • Price/Sales 1.81
  • Price/Cash Flow 4.93
  • Price/Book 1.21
Trade TAK with:

Options Overview

Details
  • Implied Volatility 26.27%
  • Historical Volatility 28.67%
  • IV Percentile 3%
  • IV Rank 2.18%
  • IV High 74.63% on 10/30/20
  • IV Low 25.19% on 11/19/20
  • Put/Call Vol Ratio 2.19
  • Today's Volume 3,010
  • Volume Avg (30-Day) 6,478
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 181,970
  • Open Int (30-Day) 200,131

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.13
  • Growth Rate Est. (year over year) +768,361.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.99 +0.95%
on 04/08/21
19.97 -14.10%
on 03/22/21
-1.29 (-7.00%)
since 03/12/21
3-Month
16.57 +3.50%
on 02/26/21
19.97 -14.10%
on 03/22/21
-1.12 (-6.13%)
since 01/12/21
52-Week
15.30 +12.07%
on 10/30/20
20.00 -14.25%
on 06/23/20
+1.10 (+6.85%)
since 04/09/20

Most Recent Stories

More News
Supernus (SUPN) Receives FDA Approval for ADHD Treatment

Supernus (SUPN) gets FDA approval for ADHD treatment, Qelbree, in pediatric patients 6 to 17 years of age.

JNJ : 161.64 (+0.24%)
RGEN : 207.02 (+0.45%)
SUPN : 27.97 (-1.20%)
TAK : 17.15 (-0.58%)
Takeda Hosts Wave 1 Pipeline Market Call

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that it will host a conference call on April 6, 2021 to provide updates on select New Molecular Entities (NMEs) in its...

TKPYY : 16.5900 (-0.90%)
TAK : 17.15 (-0.58%)
Takeda Completes Sale of Select OTC and Non-Core Assets to Orifarm

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced the completion of its previously-announced sale of a portfolio of select products to Orifarm Group ("Orifarm") for a...

TKPYY : 16.5900 (-0.90%)
TAK : 17.15 (-0.58%)
Takeda Completes Sale of Its Japan Consumer Health Care Business Unit to Blackstone

Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) ("Takeda") today announced the completion of its previously-announced sale of Takeda Consumer Healthcare Company Limited ("TCHC") to Oscar...

TKPYY : 16.5900 (-0.90%)
TAK : 17.15 (-0.58%)
Buy These Top 4 Undervalued Stocks During the Current Market Rotation

The stock market is currently experiencing a period of investment rotation in which value stocks are getting a lot of attention—at the expense of growth stocks—given their stronger potential to rebound...

TAK : 17.15 (-0.58%)
ORAN : 12.37 (-1.04%)
UHS : 139.26 (+0.78%)
INGR : 90.70 (+0.33%)
The Latest: Philippines imposes airport entry restrictions

MANILA, Philippines — The Philippine government has decided to temporarily ban the entry of foreigners and limit the entry of returning Filipinos at Manila’s international airport to 1,500 daily as...

TAK : 17.15 (-0.58%)
JNJ : 161.64 (+0.24%)
The Latest: China donates vaccine doses to UN peacekeepers

UNITED NATIONS -- China’s U.N. ambassador says China is donating 300,000 doses of COVID-19 vaccines to U.N. peacekeepers, with priority given to those serving in Africa.

JNJ : 161.64 (+0.24%)
TAK : 17.15 (-0.58%)
Takeda and IDT Support Manufacturing of Johnson & Johnson's COVID-19 Vaccine

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced a mutual agreement with IDT Biologika GmbH ("IDT"), a contract development and manufacturing organization, to utilize...

TKPYY : 16.5900 (-0.90%)
TAK : 17.15 (-0.58%)
Takeda Submits New Drug Application in Japan for Lanadelumab as a Preventive Treatment for Hereditary Angioedema Attacks

---- Takeda is committed to bringing important therapies to patients with high unmet medical needs around the world

TKPYY : 16.5900 (-0.90%)
TAK : 17.15 (-0.58%)
Takeda's Growth and Emerging Markets Business Unit Aims to Deliver Double-Digit Revenue Growth Over Next Decade(1)

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today outlined its ambition for above-market, double-digit revenue growth of its Growth and Emerging Markets Business Unit ("GEM BU")....

TKPYY : 16.5900 (-0.90%)
TAK : 17.15 (-0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide...

See More

Key Turning Points

3rd Resistance Point 17.39
2nd Resistance Point 17.33
1st Resistance Point 17.24
Last Price 17.15
1st Support Level 17.09
2nd Support Level 17.03
3rd Support Level 16.94

See More

52-Week High 20.00
Fibonacci 61.8% 18.21
Fibonacci 50% 17.65
Last Price 17.15
Fibonacci 38.2% 17.10
52-Week Low 15.30

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar